Observational Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Jun 26, 2020; 8(12): 2542-2553
Published online Jun 26, 2020. doi: 10.12998/wjcc.v8.i12.2542
Table 1 Comparison of routine detection indicators before and after chemotherapy in the toxic and non-toxic groups
Routine de-tection in-dicatorGroupT0T1T2T3T4Fwithin groupPwithin group valueFbetween groupPbetween group valueFinteractionPinteraction value
LAd (mm)Toxic3.31 ± 0.463.34 ± 0.453.40 ± 0.573.37 ± 0.623.42 ± 0.890.9210.4011.1110.3321.4420.241
Non-toxic3.21 ± 0.883.31 ± 0.693.20 ± 0.823.27 ± 0.923.23 ± 0.87
LVDd (mm)Toxic4.39 ± 0.454.47 ± 0.624.45 ± 0.654.55 ± 0.584.61 ± 0.540.9710.3821.5400.2200.2010.823
Non-toxic4.22 ± 0.634.21 ± 0.734.28 ± 0.894.30 ± 0.844.25 ± 0.93
Mitral valve E/AToxic1.34 ± 0.381.33 ± 0.371.31 ± 0.311.29 ± 0.411.27 ± 0.340.5330.5931.2510.2911.2520.473
Non-toxic1.51 ± 0.511.44 ± 0.461.47 ± 0.521.43 ± 0.461.41 ± 0.51
LVEF (%)Toxic64.92 ± 5.3863.29 ± 6.3963.27 ± 6.8362.36 ± 6.9062.39 ± 5.590.7540.6280.4730.1830.9820.377
Non-toxic65.24 ± 6.4965.37 ± 7.4964.63 ± 6.7263.93 ± 5.8963.28 ± 7.39
ΔLVEF (%)Toxic-0.93 ± 0.311.38 ± 0.381.42 ± 0.332.39 ± 0.480.5520.5791.5830.2110.9420.392
Non-toxic-0.68 ± 0.351.09 ± 0.411.28 ± 0.522.01 ± 0.45
LVFS (%)Toxic37.2 ± 3.437.4 ± 3.336.8 ± 2.936.7 ± 3.636.9 ± 3.10.7640.4721.6220.2030.7400.481
Non-toxic36.8 ± 3.637.1 ± 3.537.4 ± 4.236.4 ± 3.836.5 ± 2.9
E/e'Toxic6.36 ± 1.046.89 ± 1.387.02 ± 1.627.19 ± 1.487.82 ± 1.49a3.9120.0233.1720.0723.9610.022
Non-toxic6.17 ± 1.676.53 ± 1.586.88 ± 1.497.08 ± 1.637.32 ± 1.73
cTnI (μg/L)Toxic0.0231 ± 0.01060.0247 ± 0.01280.0256 ± 0.01930.0289 ± 0.01470.0422 ± 0.0166a5.2010.0072.9740.0844.1230.019
Non-toxic0.0204 ± 0.01480.0226 ± 0.01750.0214 ± 0.01490.0218 ± 0.01280.0228 ± 0.0145
Pro-BNP (ng/L)Toxic94.44 ± 19.3995.92 ± 19.73100.93 ± 21.49112.38 ± 20.38128.68 ± 22.29a5.5730.0053.0630.0824.4520.014
Non-toxic91.29 ± 28.9492.39 ± 31.2994.92 ± 29.3095.93 ± 28.3997.11 ± 30.61